D2Type's Latest Results
Product innovation built on rigorous clinical research
Backed by dozens of randomized controlled trials in leading journals, D2Type continuously strengthens its solutions through ongoing research and real-world data.
1.4%
A1C Reduction

in high-risk patients over three months of using D2Type's digital diabetes management platform.
BMI Reduction
10%
for type 2 diabetes (and pre-diabetes) patients after 3-month of D2Type's digital diabetes care.

≥30 min Activity
70%
Increasing daily physical activity through personalized plans and ongoing support.

D2Type's Clinical Studies
Backed by decades of clinical research, validation, and ongoing evidence generation
Our founding team brings over 30 years of experience conducting clinical studies in diabetes and cardiometabolic health.​ They have led and collaborated on numerous trials evaluating lifestyle interventions across respected academic institutions, with findings widely published in peer-reviewed journals.
D2Type's Trusted Partners







